<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/abel/Downloads/grobid-0.5.6/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Cross-reactive antibodies in convalescent SARS patients&apos; sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2013-04-10">Available online 10 April 2013</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kwok-Hung</forename><surname>Chan</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Microbiology</orgName>
								<orgName type="department" key="dep2">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">Queen Mary Hospital</orgName>
								<orgName type="institution" key="instit2">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jasper Fuk-Woo</forename><surname>Chan</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Herman</forename><surname>Tse</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Microbiology</orgName>
								<orgName type="department" key="dep2">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">Queen Mary Hospital</orgName>
								<orgName type="institution" key="instit2">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="laboratory">State Key Laboratory of Emerging Infectious Diseases</orgName>
								<orgName type="institution">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong Kong</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Kong Special Administrative Region e Guangzhou Center for Disease Control and Prevention</orgName>
								<orgName type="department" key="dep2">Carol Yu Centre for Infection</orgName>
								<orgName type="department" key="dep3">Department of Microbiology</orgName>
								<orgName type="laboratory">Special Administrative Region c Research Centre of Infection and Immunology</orgName>
								<orgName type="institution" key="instit1">The University of Hong Kong</orgName>
								<orgName type="institution" key="instit2">Hong Kong Special Administrative Region d Carol Yu Centre for Infection</orgName>
								<orgName type="institution" key="instit3">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong, Guangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">The University of Hong Kong</orgName>
								<orgName type="institution" key="instit2">Queen Mary Hospital</orgName>
								<address>
									<addrLine>102 Pokfulam Road</addrLine>
									<settlement>Pokfulam, Hong</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Honglin</forename><surname>Chen</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Microbiology</orgName>
								<orgName type="department" key="dep2">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">Queen Mary Hospital</orgName>
								<orgName type="institution" key="instit2">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="laboratory">State Key Laboratory of Emerging Infectious Diseases</orgName>
								<orgName type="institution">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong Kong</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Kong Special Administrative Region e Guangzhou Center for Disease Control and Prevention</orgName>
								<orgName type="department" key="dep2">Carol Yu Centre for Infection</orgName>
								<orgName type="department" key="dep3">Department of Microbiology</orgName>
								<orgName type="laboratory">Special Administrative Region c Research Centre of Infection and Immunology</orgName>
								<orgName type="institution" key="instit1">The University of Hong Kong</orgName>
								<orgName type="institution" key="instit2">Hong Kong Special Administrative Region d Carol Yu Centre for Infection</orgName>
								<orgName type="institution" key="instit3">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong, Guangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">The University of Hong Kong</orgName>
								<orgName type="institution" key="instit2">Queen Mary Hospital</orgName>
								<address>
									<addrLine>102 Pokfulam Road</addrLine>
									<settlement>Pokfulam, Hong</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Candy Choi-Yi</forename><surname>Lau</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Microbiology</orgName>
								<orgName type="department" key="dep2">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">Queen Mary Hospital</orgName>
								<orgName type="institution" key="instit2">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian-Piao</forename><surname>Cai</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Microbiology</orgName>
								<orgName type="department" key="dep2">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">Queen Mary Hospital</orgName>
								<orgName type="institution" key="instit2">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alan</forename></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ka-Lun</forename><surname>Tsang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Microbiology</orgName>
								<orgName type="department" key="dep2">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">Queen Mary Hospital</orgName>
								<orgName type="institution" key="instit2">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xincai</forename><surname>Xiao</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Microbiology</orgName>
								<orgName type="department" key="dep2">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">Queen Mary Hospital</orgName>
								<orgName type="institution" key="instit2">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kelvin</forename></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kai-Wang</forename><surname>To</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Microbiology</orgName>
								<orgName type="department" key="dep2">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">Queen Mary Hospital</orgName>
								<orgName type="institution" key="instit2">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="laboratory">State Key Laboratory of Emerging Infectious Diseases</orgName>
								<orgName type="institution">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong Kong</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Kong Special Administrative Region e Guangzhou Center for Disease Control and Prevention</orgName>
								<orgName type="department" key="dep2">Carol Yu Centre for Infection</orgName>
								<orgName type="department" key="dep3">Department of Microbiology</orgName>
								<orgName type="laboratory">Special Administrative Region c Research Centre of Infection and Immunology</orgName>
								<orgName type="institution" key="instit1">The University of Hong Kong</orgName>
								<orgName type="institution" key="instit2">Hong Kong Special Administrative Region d Carol Yu Centre for Infection</orgName>
								<orgName type="institution" key="instit3">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong, Guangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">The University of Hong Kong</orgName>
								<orgName type="institution" key="instit2">Queen Mary Hospital</orgName>
								<address>
									<addrLine>102 Pokfulam Road</addrLine>
									<settlement>Pokfulam, Hong</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susanna Kar-Pui</forename><surname>Lau</surname></persName>
							<affiliation key="aff1">
								<orgName type="laboratory">State Key Laboratory of Emerging Infectious Diseases</orgName>
								<orgName type="institution">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong Kong</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Kong Special Administrative Region e Guangzhou Center for Disease Control and Prevention</orgName>
								<orgName type="department" key="dep2">Carol Yu Centre for Infection</orgName>
								<orgName type="department" key="dep3">Department of Microbiology</orgName>
								<orgName type="laboratory">Special Administrative Region c Research Centre of Infection and Immunology</orgName>
								<orgName type="institution" key="instit1">The University of Hong Kong</orgName>
								<orgName type="institution" key="instit2">Hong Kong Special Administrative Region d Carol Yu Centre for Infection</orgName>
								<orgName type="institution" key="instit3">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong, Guangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">The University of Hong Kong</orgName>
								<orgName type="institution" key="instit2">Queen Mary Hospital</orgName>
								<address>
									<addrLine>102 Pokfulam Road</addrLine>
									<settlement>Pokfulam, Hong</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrick</forename><surname>Chiu-Yat Woo</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Microbiology</orgName>
								<orgName type="department" key="dep2">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">Queen Mary Hospital</orgName>
								<orgName type="institution" key="instit2">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="laboratory">State Key Laboratory of Emerging Infectious Diseases</orgName>
								<orgName type="institution">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong Kong</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Kong Special Administrative Region e Guangzhou Center for Disease Control and Prevention</orgName>
								<orgName type="department" key="dep2">Carol Yu Centre for Infection</orgName>
								<orgName type="department" key="dep3">Department of Microbiology</orgName>
								<orgName type="laboratory">Special Administrative Region c Research Centre of Infection and Immunology</orgName>
								<orgName type="institution" key="instit1">The University of Hong Kong</orgName>
								<orgName type="institution" key="instit2">Hong Kong Special Administrative Region d Carol Yu Centre for Infection</orgName>
								<orgName type="institution" key="instit3">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong, Guangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">The University of Hong Kong</orgName>
								<orgName type="institution" key="instit2">Queen Mary Hospital</orgName>
								<address>
									<addrLine>102 Pokfulam Road</addrLine>
									<settlement>Pokfulam, Hong</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bo-Jiang</forename><surname>Zheng</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Microbiology</orgName>
								<orgName type="department" key="dep2">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">Queen Mary Hospital</orgName>
								<orgName type="institution" key="instit2">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="laboratory">State Key Laboratory of Emerging Infectious Diseases</orgName>
								<orgName type="institution">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong Kong</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Kong Special Administrative Region e Guangzhou Center for Disease Control and Prevention</orgName>
								<orgName type="department" key="dep2">Carol Yu Centre for Infection</orgName>
								<orgName type="department" key="dep3">Department of Microbiology</orgName>
								<orgName type="laboratory">Special Administrative Region c Research Centre of Infection and Immunology</orgName>
								<orgName type="institution" key="instit1">The University of Hong Kong</orgName>
								<orgName type="institution" key="instit2">Hong Kong Special Administrative Region d Carol Yu Centre for Infection</orgName>
								<orgName type="institution" key="instit3">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong, Guangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">The University of Hong Kong</orgName>
								<orgName type="institution" key="instit2">Queen Mary Hospital</orgName>
								<address>
									<addrLine>102 Pokfulam Road</addrLine>
									<settlement>Pokfulam, Hong</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ming</forename><surname>Wang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Microbiology</orgName>
								<orgName type="department" key="dep2">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">Queen Mary Hospital</orgName>
								<orgName type="institution" key="instit2">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kwok-Yung</forename><surname>Yuen</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Microbiology</orgName>
								<orgName type="department" key="dep2">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">Queen Mary Hospital</orgName>
								<orgName type="institution" key="instit2">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="laboratory">State Key Laboratory of Emerging Infectious Diseases</orgName>
								<orgName type="institution">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong Kong</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Kong Special Administrative Region e Guangzhou Center for Disease Control and Prevention</orgName>
								<orgName type="department" key="dep2">Carol Yu Centre for Infection</orgName>
								<orgName type="department" key="dep3">Department of Microbiology</orgName>
								<orgName type="laboratory">Special Administrative Region c Research Centre of Infection and Immunology</orgName>
								<orgName type="institution" key="instit1">The University of Hong Kong</orgName>
								<orgName type="institution" key="instit2">Hong Kong Special Administrative Region d Carol Yu Centre for Infection</orgName>
								<orgName type="institution" key="instit3">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong, Guangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Kong Special Administrative Region</orgName>
								<orgName type="institution" key="instit1">The University of Hong Kong</orgName>
								<orgName type="institution" key="instit2">Queen Mary Hospital</orgName>
								<address>
									<addrLine>102 Pokfulam Road</addrLine>
									<settlement>Pokfulam, Hong</settlement>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Cross-reactive antibodies in convalescent SARS patients&apos; sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2013-04-10">Available online 10 April 2013</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.1016/j.jinf.2013.03.015</idno>
					<note type="submission">Accepted 31 March 2013</note>
					<note>f The authors contributed equally to the manuscript. 0163-4453/$36 ª</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>

		<encodingDesc>
			<appInfo>
				<application version="0.5.6" ident="GROBID" when="2020-03-16T22:29+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>		<profileDesc>
			<textClass>
				<keywords>
					<term>Coronavirus</term>
					<term>Betacoronavirus</term>
					<term>EMC</term>
					<term>SARS</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Objectives: A severe acute respiratory syndrome (SARS)-like disease due to a novel betacoronavirus, human coronavirus EMC (HCoV-EMC), has emerged recently. HCoV-EMC is phylogenetically closely related to Tylonycteris-bat-coronavirus-HKU4 and Pipistrellus-bat-coronavirus-HKU5 in Hong Kong. We conducted a seroprevalence study on archived sera from 94 game-food animal handlers at a wild life market, 28 SARS patients, and 152 healthy blood * Corresponding author.</p><p>Journal of Infection (2013) 67, 130e140 OC43; HKU1; Cross-reactive; Antibody; Neutralization; Seroprevalence donors in Southern China to assess the zoonotic potential and evidence for intrusion of HCoV-EMC and related viruses into humans. Methods: Anti-HCoV-EMC and anti-SARS-CoV antibodies were detected using screening indirect immunofluorescence (IF) and confirmatory neutralizing antibody tests. Results: Two (2.1%) animal handlers had IF antibody titer of !1:20 against both HCoV-EMC and SARS-CoV with neutralizing antibody titer of &lt;1:10. No blood donor had antibody against either virus. Surprisingly, 17/28 (60.7%) of SARS patients had significant IF antibody titers with 7/28 (25%) having anti-HCoV-EMC neutralizing antibodies at low titers which significantly correlated with that of HCoV-OC43. Bioinformatics analysis demonstrated a significant B-cell epitope overlapping the heptad repeat-2 region of Spike protein. Virulence of SARS-CoV over other betacoronaviruses may boost cross-reactive neutralizing antibodies against other betacoronaviruses. Conclusions: Convalescent SARS sera may contain cross-reactive antibodies against other betacoronaviruses and confound seroprevalence study for HCoV-EMC.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>The emergence of the novel human coronavirus EMC (HCoV-EMC) in the Middle East since April 2012 has so far led to 17 cases of human infection with 11 being fatal as of <ref type="bibr">26 March 2013. 1e3</ref> The first 2 laboratory-confirmed cases were reported by the World Health Organization (WHO) on 23 September 2012. <ref type="bibr" target="#b0">1</ref> The index case was a 60-year-old man from Jeddah, the Kingdom of Saudi Arabia, who presented with severe acute community-acquired pneumonia and acute renal failure on 6 June 2012 and later succumbed on 24 June 2012 despite maximal supportive treatment. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b3">4</ref> A sputum sample obtained on admission showed cytopathic changes suggestive of virus replication in LLC-MK2 and Vero cells, and was positive for coronavirus by pan-coronavirus RT-PCR. Subsequent phylogenetic analysis of the viral genome sequences showed that the virus was a novel coronavirus with close genetic relatedness to Tylonycteris-bat-coronavirus-HKU4 (Ty-BatCoV-HKU4) and Pipistrellus-bat-coronavirus-HKU5 (Pi-BatCoV-HKU5) discovered in the lesser bamboo bat (Tylonycteris pachypus) and Japanese Pipistrelle bat (Pipistrellus abramus) of Hong Kong, China respectively. 4e7 Closely related coronaviruses have also been found in other bat species in Europe and Ghana. <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9</ref> The second case was a 49-year-old man from Qatar who kept camels and sheep in his farm and had a travel history to the Kingdom of Saudi Arabia before symptom onset. 1, <ref type="bibr" target="#b9">10</ref> He developed severe acute communityacquired pneumonia and acute renal failure requiring extracorporeal membrane oxygenation in an intensive care unit of London. The lower respiratory tract samples were positive for coronavirus using pan-coronavirus RT-PCR. The 250 bp PCR fragments of the viral isolates in the first 2 cases showed 99.5% sequence homology with only 1 nucleotide mismatch over the regions compared. <ref type="bibr" target="#b9">10</ref> Subsequently, 15 more laboratory-confirmed cases of HCoV-EMC infection were reported in the Middle East and the United Kingdom with a total of 9 in the Kingdom of Saudi Arabia, 2 in Qatar, 2 in Jordan, 1 in United Arab Emirates and 3 in the United Kingdom. <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b2">3</ref> Most of the cases developed severe pneumonia, at least 6 cases had concomitant acute renal failure, and 11 cases died. This unusually high crude fatality rate of over 50% and the severe clinical manifestations of acute respiratory and renal failure are unique among human coronavirus infections. <ref type="bibr">11e18</ref> The source, transmissibility and seroprevalence of HCoV-EMC are not well established at present. As with other highly pathogenic viruses which are capable of causing epidemics such as SARS coronavirus (SARS-CoV) and avian H5N1 influenza A virus, an animal source of the virus leading to interspecies jumping to humans is possible. <ref type="bibr">7,11,19e22</ref> This hypothesis is supported by the epidemiological link to animal exposure in some of these patients with laboratory-confirmed HCoV-EMC infection, 1,3 the close phylogenetic relatedness between HCoV-EMC and Ty-BatCoV HKU4 and Pi-BatCoV HKU5, 5,6 and the broad species tropism of HCoV-EMC in different animal cells including bat, primate, swine, civet, and rabbit. <ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24</ref> Human-to-human transmission appears to be limited at this stage with only 4 epidemiologically-linked clusters being identified so far. The Jordanian cluster was retrospectively traced back to April 2012 with no further evidence of spread. Moreover, none of 2400 residents in the Kingdom of Saudi Arabia had serum antibody against HCoV-EMC. <ref type="bibr" target="#b3">4</ref> Thus, HCoV-EMC is likely different from other human coronaviruses associated with mild respiratory tract infections, namely HCoV-OC43, HCoV-229E, HCoV-NL63 and HCoV-HKU1 which account for 5e30% of all respiratory infections with up to 21.6% of the general population having serum antibodies. <ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26</ref> Rather, it may be similar to SARS-CoV which crossed species barriers from its natural bat reservoir to intermediate amplification animal hosts and humans and caused severe infection or subclinical non-pneumonic infection in about 0.5% of the general population. <ref type="bibr" target="#b11">12</ref> In order to further substantiate the hypothesis of HCoV-EMC being a zoonotic agent and elicit evidence for intrusion of HCoV-EMC and its related viruses into humans, we studied the antibody titers using immunofluorescence (IF) as screening and neutralization as confirmatory tests in at-risk groups working in a wild life market in Guangzhou of Southern China who were constantly exposed to a wide range of game food animals, SARS patients who might have acquired their infection directly from wild animals, and healthy blood donors.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head><p>The study was approved by the Institutional Review Board of the Hospital Authority in Hong Kong.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Subjects and sera</head><p>Archived sera obtained from 94 subjects belonging to at-risk groups working in a wild life market in Guangzhou, 28 patients with laboratory-confirmed SARS by RT-PCR, and 152 healthy blood donors in Hong Kong Special Administrative Region, Southern China were retrieved from À70 C refrigerator. The at-risk groups consisted of game food animal market retailers, animal slaughterers and animal transporting personnel. All subjects were aged 18 years or above. The 94 animal handlers had a mean age of 35.4 years (range, 19e76 years), and the male-to-female ratio was 60:34. All of them had exposure to live and/or dead chickens, ducks, geese, pigeons, sparrows, seagulls, turtledoves, cranes, foxes, wild boars, sika deers, rabbits, and/or cats. Their average exposure time was 3.91 years (range, 1 month to 16 years).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Viral isolate</head><p>A clinical isolate of HCoV-EMC was kindly provided by Fouchier and Zaki et al. <ref type="bibr" target="#b3">4</ref> The isolate was amplified by one additional passage in Vero cell lines to make working stocks of the virus. All experimental protocol involving live HCoV-EMC coronavirus isolate followed the standard operating procedures of the approved biosafety level-3 facility as we previously described. <ref type="bibr" target="#b26">27</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Preparation of antigens of human betacoronaviruses as infected cell smears</head><p>HCoV-EMC and SARS-CoV-infected Vero, HCoV-OC43infected BSC-1, HCoV-229E-infected MRC-5 and HCoV-NL63-infected LLC-MK2 cell smears were used for the study. Smears were prepared as we previously described. <ref type="bibr" target="#b27">28</ref> Briefly, when 60%e70% of cells had early evidence of cytopathic effect (CPE) as shown by rounding up of cells under inverted microscopy, the cells were harvested by trypsinization and air dried on Tefllon slides (Immuno-cell Int, Mechelen, Belgium), and fixed with chilled acetone for 10 min at À20 C and were stored at À80 C until use.</p><p>Indirect immunofluorescent antibody test ( <ref type="figure" target="#fig_0">Fig. 1</ref>) Anti-HCoV-EMC and anti-SARS-CoV IF antibody detection was performed using indirect IF as we previously described with slight modifications. <ref type="bibr" target="#b27">28</ref> Sera were screened at a dilution of 1 in 20 on infected and non-infected control cells at 37 C for 45 min. The cells were washed twice in PBS for 5 min each time. Anti-human IgG (INOVA Diagnostic, San Diego) were then added and the cell smears further incubated for 45 min at 37 C. Sera positive at a screening dilution of 1 in 20 were further titrated with serial 2-fold dilutions. A positive result was scored when fluorescent intensity equaled or was higher than that of a positive control used in our previous studies. 28e32 For HCoV-EMC antibody testing, Vero cells were infected with 0.01 MOI for 36e40 h before harvesting. The infected cells were then coated on Teflon slides 8-well, air dried and fixed with chilled acetone at 20 C for 10 min, and kept at À80 C until use. Guinea pig anti-N hyper-immune sera were prepared as positive controls for testing with each new batch of infected and non-infected cells together with non-immune guinea pig sera as a negative control. <ref type="bibr" target="#b22">23</ref> Positive and negative guinea control sera were included in each run of antibody testing. The IF antibody titer was taken to be the highest serum dilution giving a positive result. Anti-HCoV-OC43 IF antibody titers were further determined for sera with positive anti-HCoV-EMC IF antibody titers.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Neutralizing antibody test</head><p>All sera were inactivated at 56 C for 30 min before neutralizing antibody test. Starting with a serum dilution of 1 in 10, serial 2-fold dilutions of sera were prepared in 96-well microtiter plates as we have previously described. <ref type="bibr" target="#b27">28</ref> Each serum dilution of 0.05 ml was mixed with 0.05 ml of 200 50% tissue culture infectious doses (TCID 50 ) of HCoV-EMC or SARS-CoV (HK39849), and incubated at 37 C for 1.5 h in a CO 2 incubator. Then 0.1 ml of the virus-serum mixture was inoculated in duplicate wells of 96-well microtiter plates with preformed monolayers of Vero cells and further incubated at 37 C for 3e4 days. A virus backtitration was performed to assess the actual virus titer used in each experiment. CPE was observed using an inverted microscope on day 3 and 4 post-inoculation. The neutralizing antibody titer was determined as the highest dilution of serum which completely suppresses the CPE in at least half of the infected wells. The experiment was read when the virus back-titration showed the virus dose to be 100 TCID 50 as expected. Mouse anti-whole HCoV-EMC hyper-immune sera were used as positive controls. All sera with positive neutralizing antibody titers were repeated for confirmation. Anti-HCoV-OC43 neutralizing antibody titers were further determined for sera with positive HCoV-EMC IF antibody titers.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Bioinformatic analysis of spike proteins</head><p>Amino acid sequences of the S proteins of HCoV-EMC, SARS-CoV, HCoV-OC43 and HCoV-HKU1 were downloaded from NCBI GenBank. Structure-based sequence alignment of the S1 and S2 domains of HCoV-EMC, SARS-CoV, HCoV-OC43 and HCoV-HKU1 were performed by PROMALS3D server. <ref type="bibr" target="#b32">33</ref> Immunogenic regions containing potential human B-cell epitopes were predicted using Epitopia. <ref type="bibr" target="#b33">34</ref> The transmembrane domain preceding the cytoplasmic tail was predicted using TMHMM version 2.0. <ref type="bibr" target="#b34">35</ref> Heptad repeat regions within the S2 domains were predicted using MARCOIL. <ref type="bibr" target="#b35">36</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p>Fisher exact test was used to determine the differences in proportion of the 3 groups with positive antibody titers by IF and NT between animal handlers and healthy blood donors, SARS patients and healthy blood donors, and animal handlers and SARS patients. Computation was performed using the Predictive Analytics Soft Ware (PASW) Version 18.0 for Windows. Correlation between the IF and neutralizing antibody titers against HCoV-EMC, SARS-CoV and HCoV-OC43 was performed using IBM SPSS Statistics 19, with titers of &lt;1:20 and &lt;1:10 regarded as 1:10 and 1:5 respectively. A p-value of &lt;0.05 was considered as statistically significant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Indirect IF and neutralizing antibody titers</head><p>Two of 94 (2.1%) animal handlers working at a wild game food animal market in South China had positive anti-HCoV-EMC IgG detected by indirect IF with titer of 1:20 and 1:40 <ref type="table" target="#tab_0">(Table 1)</ref>. Case 1 was a 38-year-old man with exposure to pigeons for more than 2 years. Case 2 was a 39-year-old man with exposure to chickens, ducks, and geese for more than 3 years. Both of them also had positive anti-SARS-CoV IgG by indirect IF with a titer of 1:40 and anti-HCoV-OC43 IgG with titers &gt;Z1:320 <ref type="table" target="#tab_2">(Table 2</ref>). Case 2 who had adequate archived serum for testing of anti-HCoV-OC43 neutralizing antibody had a titer of 1:80. Another 11 animal handlers had positive anti-SARS-CoV IgG by indirect IF and 4 of them had anti-SARS-CoV neutralizing antibodies ( <ref type="table" target="#tab_0">Table 1)</ref>. None of the animal handlers had anti-HCoV-EMC neutralizing antibody.</p><p>Among the 28 SARS patients, 17 (60.7%) had positive anti-HCoV-EMC IgG detected by indirect IF with titers ranging from 1:20 to 1:320 <ref type="table" target="#tab_0">(Table 1)</ref>. Most had a titer between 1:80 to 1:160 (6/28 or 21.4% each). All 17 patients had anti-HCoV-OC43 IgG detected by indirect IF <ref type="table" target="#tab_2">(Table 2)</ref>. Surprisingly, 7 (25%) of the SARS patients also had low titers of anti-HCoV-EMC neutralizing antibody of 1:20 or less, and all 17 of them had anti-HCoV-OC43 neutralizing antibodies. Anti-SARS-CoV IF and neutralizing antibodies were found in the majority (96.4%) of the SARS patients as expected. Most of them had high titers of 1:80 or above. Four of the 28 SARS patients had paired acute and convalescent sera available for comparison ( <ref type="table">Table 3</ref>). The anti-HCoV-EMC IF IgG titer rose from &lt;1:20 in the acute sera to 1:40 and 1:320 in the convalescent sera in 2 of these patients, while there was no significant rise in the other two. These patients also had 4-fold rise in IF antibody titer against another human betacoronavirus HCoV-OC43.</p><p>None of 152 (0%) healthy blood donors had anti-HCoV-EMC or anti-SARS-CoV antibodies by indirect IF and neutralization <ref type="table" target="#tab_0">(Table 1</ref>). There was an overall significant correlation between the indirect IF IgG titers against HCoV-EMC and SARS-CoV (Pearson correlation 0.587, p &lt; 0.01), and between the neutralizing antibody titers against HCoV-EMC and SARS-CoV (Pearson correlation 0.422, p &lt; 0.01). For subgroup analysis of SARS patients with positive anti-HCoV-EMC IF and/or neutralizing antibodies, the correlation was strongest between antibodies against SARS-CoV and HCoV-OC43 (Pearson correlation 0.593 and 0.605 for IF and neutralizing antibodies respectively; p &lt; 0.01 in both cases).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Bioinformatic analysis of spike proteins</head><p>While there was little amino acid sequence identity (16.6%) between the receptor-binding domain in the S1 proteins of HCoV-EMC and SARS-CoV, their S2 proteins showed an amino acid sequence identity of 40.3%. Epitopia was used to predict immunogenic regions that might be B-cell epitopes in the S1 and S2 domains. <ref type="bibr" target="#b33">34</ref> While epitopes were predicted in aligned regions of S1 from HCoV-EMC and SARS-CoV, it is unlikely that cross-neutralization by antibodies would occur in these regions as the sequence identity of the predicted epitopes between the two viruses is low <ref type="figure">(Fig. 2)</ref>. Three and two immunogenic regions were predicted in the S2 domains of HCoV-EMC and SARS-CoV respectively <ref type="figure">(Fig. 3)</ref>. The immunogenic regions identified in S2 of HCoV-EMC overlapped the predicted regions in S2 of SARS-CoV. Notably, the identified immunogenic regions sars-I and emc-II overlapped the heptad repeat 2 region of the S2 domain of both HCoV-EMC and SARS-CoV, which is known to harbor an epitope for broadly neutralizing antibody in the case of SARS-CoV. <ref type="bibr" target="#b36">37</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>While looking for evidence of intrusion by the novel betacoronavirus HCoV-EMC into at-risk groups and the general population, convalescent SARS patients' sera were found to contain significant titers of antibodies against other betacoronaviruses. There was a positive correlation between the antibody titers against the SARS-CoV and HCoV-EMC using both the indirect IF and neutralization antibody tests. The finding of cross-reactive IF antibodies was not that unexpected because these could be induced by crossreactive epitopes against structural proteins such as the nucleoprotein which is the most abundant structural protein in the coronaviruses as we had previously reported. <ref type="bibr" target="#b37">38</ref> Indeed, cross-reactive antibodies among human betacoronaviruses by IF are well known, and have made large scale surveillance studies and epidemiologic surveys of human coronavirus infections difficult. <ref type="bibr" target="#b38">39</ref> On the other hand, crossreactive neutralizing antibodies among betacoronaviruses have rarely been reported except between the closely related human and palm civet SARS-CoVs. <ref type="bibr" target="#b39">40</ref> The significant neutralizing antibody titers against HCoV-EMC in SARS patients' sera in this study were surprising because neutralization is generally considered as the most specific serological test. Our previous surveillance study showed that anti-SARS-CoV neutralizing antibody in our population was extremely low despite a high seroprevalence of anti-HCoV-OC43 and anti-HCoV-HKU1 antibodies. <ref type="bibr" target="#b11">12</ref> Zaki and colleagues also failed to detect cross-reactive anti-HCoV-EMC antibodies among 2400 patients in the Kingdom of Saudi Arabia who likely also had serum anti-HCoV-OC43 and/or anti-HCoV-HKU1 antibodies. Furthermore, none of the 152 healthy blood donors in the present study had serum anti-HCoV-EMC antibodies detected by indirect IF and neutralization. Therefore we assessed the structural homologies between these betacoronaviruses for possible explanations of the observed cross-reactive neutralizing antibodies.</p><p>Of all the surface proteins, only the ectodomains of S (spike) and Orf3a can induce significant neutralizing antibody with some augmentation from the M (matrix) and E (envelope) proteins. <ref type="bibr" target="#b40">41,</ref><ref type="bibr" target="#b41">42</ref> Though Orf3a is absent in HCoV-EMC, we cannot completely exclude the possibility that similar Orf3a-like proteins are being coded by the accessory protein gene but homology search does not reveal the presence of similar protein. All betacoronaviruses use the S protein for attachment and fusion of the virion with the host cell membrane. Trimers of the S protein form the peplomers that radiate from the lipid envelope and give the virus a characteristic corona solis-like appearance under the electron microscope. The spike protein ectodomain consists of the S1 and S2 domains. The S1 domain contains the receptor binding domain and is responsible for recognition and binding to the host cell receptor. The S1 fragment between amino acids 318 and 510 is the receptor binding domain for ACE2 in the case of SARS-CoV. However, the homology of S1 between SARS-CoV and HCoV-EMC is low with only 16.6% amino acid identity. Indeed, this region is generally more divergent relative to the S2 region for coronaviruses. Hence, while the S1 region induces the majority of the neutralizing antibody in convalescent sera of SARS patients, <ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b43">44</ref> it would be unlikely to result in antibodies with significant cross-neutralizing activity.</p><p>The S2 domain, responsible for fusion, contains the putative fusion peptide and the heptad repeat HR1 and HR2. The binding of S1 to the cellular receptor will trigger conformational changes which collocates the fusion peptide upstream of the two heptad repeats of S2 to the transmembrane domain, and, finally, fusion of the viral and cellular lipid envelopes. An epitope situated between amino acids 1055 to 1192 and around heptad repeat 2 of the S2 subunit is likely to have induced the cross-reactivity of neutralizing antibody against HCoV-EMC and SARS-CoV. <ref type="bibr" target="#b62">63</ref> Our phylogenetic and antigenic epitope analysis suggested that this area is highly conserved among these 4 <ref type="table">Table 3</ref> Titers of anti-human-coronaviruses antibodies by immunofluorescence and/or neutralization in SARS patients with available paired acute and convalescent serum samples.  <ref type="table">Table 3</ref> and Case 3 in <ref type="table" target="#tab_2">Table 2</ref> were the same specimens. b Case D (convalescent) in <ref type="table">Table 3</ref> and Case 17 in <ref type="table" target="#tab_2">Table 2</ref> were the same specimens.  <ref type="table" target="#tab_2">Table 2</ref> and Case C (convalescent) in <ref type="table">Table 3</ref> were the same specimens. b Case 17 in <ref type="table" target="#tab_2">Table 2</ref> and Case D (convalescent) in <ref type="table">Table 3</ref> were the same specimens. c Test was not performed due to insufficient quantity of archived sera.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HCoV-EMC IF HCoV-EMC NT SARS-CoV IF SARS-CoV NT</head><p>betacoronaviruses and therefore could not completely explain the presence of cross-reactive anti-HCoV-EMC neutralizing antibodies among SARS patients but not the general population. We postulate that in addition to the structural homologies between HCoV-EMC, SARS-CoV, HCoV-OC43 and HCoV-HKU1, the different clinical manifestations and subsequent host immunological response of these infections may account for this pattern of neutralizing antibody cross-reactivity. While SARS-CoV causes severe infection with viremia, <ref type="bibr" target="#b44">45</ref> HCoV-OC43 and HCoV-HKU1 predominantly cause superficial mucosal infections of the upper respiratory tract which is self-limiting. Therefore unlike the highly virulent SARS-CoV or HCoV-EMC which can induce a solid humoral immune response, an insufficient B cell maturation process with failure to induce high avidity antibodies is more likely to occur with <ref type="figure">Figure 2</ref> Structure-based protein sequence alignment of the S1 region of HCoV-EMC, SARS-CoV, HCoV-OC43 and HCoV-HKU1, constructed using PROMALS3D (http://prodata.swmed.edu/promals3d/). The receptor binding domain is highlighted. Identical and similar residues are shaded in black and grey respectively. Immunogenic regions predicted by Epitopia of at least 10 residues in length are highlighted by a black line. Only 1 representative sequence from each virus is used to improve clarity of presentation.</p><p>other betacoronavirus infections in the general population but their neutralizing antibody titer against these less virulent betacoronaviruses such as HCoV-OC43 can be boosted with superimposed SARS-CoV or HCoV-EMC infections ( <ref type="table" target="#tab_2">Table 2)</ref>. These viral, clinical and immunological differences may explain the absence of cross-reactive neutralizing antibody against both SARS-CoV and HCoV-EMC in normal blood donors despite that most of them should have been exposed to HCoV-OC43 and HCoV-HKU1 in the past. Our finding has important implications in the serodiagnostic testing, treatment and development of vaccine for the prevention of human infection caused by betacoronaviruses. The possibility of cross-reactive antibodies giving rise to false-positive results concurs with the suggestion of a recent report to use anti-HCoV-EMC IF antibody test only in patients with very clear epidemiological linkage. <ref type="bibr" target="#b45">46</ref> Besides the possibility of wrong serodiagnosis due to crossreactivity, this observation would support the use of antiviral peptides in the treatment of this emerging HCoV-EMC infection as antiviral peptides targeting the heptad repeat 2 has been successfully used in neutralizing SARS-CoV in cell culture. <ref type="bibr" target="#b46">47</ref> Furthermore, this antigenic epitope could be an important vaccine target though the danger of immunopathology must also be considered. The possibility of low level neutralizing antibody leading to immune enhancement should also be considered if SARS convalescent plasma or normal intravenous immunoglobulin are used for the treatment of HCoV-EMC infection. <ref type="bibr" target="#b47">48</ref> No definitive evidence of intrusion of HCoV-EMC into atrisk groups was found in the present study. Two out of 94 sera from animal handlers had indirect IF antibody against both HCoV-EMC and SARS-CoV but no specific neutralizing activity toward these 2 viruses. Though this can be due to cross-reactivity with any betacoronaviruses such as HCoV-OC43, the possibility of cross-reactivity to Ty-BatCoV HKU4 and Pi-BatCoV HKU5 remains a distinct possibility which may represent sporadic interspecies jumping in this high risk group. Indeed, coronaviruses are found in many mammalian and avian species, 49e53 and have repeatedly crossed species barriers to cause interspecies transmission throughout history and occasionally caused major zoonotic outbreaks with disastrous consequences. <ref type="bibr">11,54e56</ref> Phylogenetic analysis showed that the lineage A betacoronavirus HCoV-OC43 might have jumped from a bovine source into <ref type="figure">Figure 3</ref> Structure-based protein sequence alignment of the S2 region of HCoV-EMC, SARS-CoV, HCoV-OC43 and HCoV-HKU1 constructed using PROMALS3D (http://prodata.swmed.edu/promals3d/). Identical and similar residues are shaded in black and grey respectively. Immunogenic regions predicted by Epitopia of at least 20 residues in length are highlighted by a black line. The heptad repeat regions are highlighted. Only 1 representative sequence from each virus is used to improve clarity of presentation. human in the 1890s. <ref type="bibr" target="#b56">57</ref> The more recent example of interspecies transmission was the jumping of the lineage B betacoronavirus SARS-CoV from bats to civets and then to humans which caused the SARS epidemic in 2003. <ref type="bibr">11,19,58e62</ref> Though the seroprevalence of anti-HCoV-EMC antibody found no indication of positivity among residents in the Kingdom of Saudi Arabia, their demographic details, particularly the history of animal exposure, were not described. <ref type="bibr" target="#b3">4</ref> Further studies including seroprevalence studies with more refined serological test should be conducted among at-risk groups in the Middle East to confirm the zoonotic nature of this emerging human coronavirus.</p><p>There were a number of limitations in this study. First, only a relatively small number of SARS patients were tested because of the lack of archived sera. However, most of the positive anti-HCoV-EMC IgG titers in this group were of high values between 1:80 to 1:160 which made the results less ambiguous. It would be interesting to test a larger group of laboratory-confirmed SARS patients with different viral strains to substantiate our observation. Second, the low seroprevalence of anti-SARS-CoV in the general population make the possibility of wrong serodiagnostics due to crossreactivity less important for routine diagnostics. However, the finding is essential for confirmation of serological surveillance studies especially in some Southeast Asian countries including China where the seroprevalence for anti-SARS-CoV may not be well established, as HCoV-EMC may continue to spread and cause an epidemic in this densely populated area in the future.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc>Indirect immunofluorescent antibody test for anti-HCoV-EMC IgG. (1A): positive; (1B): borderline; (1C): negative.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0" validated="true"><head>Table 1</head><label>1</label><figDesc>Titers of anti-HCoV-EMC and anti-SARS-CoV antibodies by immunofluorescence and neutralization among animal handlers, SARS patients and healthy blood donors.</figDesc><table>HCoV-EMC IF 
HCoV-EMC NT 
SARS-CoV IF 
SARS-CoV NT 

Animal handlers 
&lt;1:20 
92 (97.9%) &lt;1:10 
94 (100%) &lt;1:20 
81 (86.2%) &lt;1:10 
90 (95.7%) 
(n Z 94) 
1:20 
1 (1.1%) 
1:10 
0 (0%) 
1:20 
6 (6.4%) 
1:10 
1 (1.1%) 
1:40 
1 (1.1%) 
1:20 
0 (0%) 
1:40 
7 (7.4%) 
1:20 
3 (3.2%) 
1:80 
0 (0%) 
1:40 
0 (0%) 
1:80 
0 (0%) 
1:40 
0 (0%) 
1:160 
0 (0%) 
1:80 
0 (0%) 
1:160 
0 (0%) 
1:80 
0 (0%) 
!1:320 
0 (0%) 
!1:160 
0 (0%) 
!1:320 
0 (0%) 
!1:160 
0 (0%) 
SARS patients 
&lt;1:20 
11 (39.3%) &lt;1:10 
21 (75.0%) &lt;1:20 
1 (3.6%) 
&lt;1:10 
1 (3.6%) 
(n Z 28) 
1:20 
1 (3.6%) 
1:10 
5 (17.9%) 1:20 
0 (0%) 
1:10 
0 (0%) 
1:40 
3 (10.7%) 1:20 
2 (7.1%) 
1:40 
0 (0%) 
1:20 
1 (3.6%) 
1:80 
6 (21.4%) 1:40 
0 (0%) 
1:80 
0 (0%) 
1:40 
0 (0%) 
1:160 
6 (21.4%) 1:80 
0 (0%) 
1:160 
5 (17.9%) 1:80 
13 (46.4%) 
!1:320 
1 (3.6%) 
!1:160 
0 (0%) 
!1:320 
22 (78.6%) !1:160 
13 (46.4%) 
Healthy blood 
donors 

&lt;1:20 
152 (100%) &lt;1:10 
152 (100%) &lt;1:20 
152 (100%) &lt;1:10 
152 (100%) 

(n Z 152) 
1:20 
0 (0%) 
1:10 
0 (0%) 
1:20 
0 (0%) 
1:10 
0 (0%) 
1:40 
0 (0%) 
1:20 
0 (0%) 
1:40 
0 (0%) 
1:20 
0 (0%) 
1:80 
0 (0%) 
1:40 
0 (0%) 
1:80 
0 (0%) 
1:40 
0 (0%) 
1:160 
0 (0%) 
1:80 
0 (0%) 
1:160 
0 (0%) 
1:80 
0 (0%) 
!1:320 
0 (0%) 
!1:160 
0 (0%) 
!1:320 
0 (0%) 
!1:160 
0 (0%) 
No. of patients with significant antibody titer a 
Animal handlers 
vs SARS 
patients 

2/94 vs 17/28 p &lt; 0.01 0/94 vs 7/28 p &lt; 0.01 13/94 vs 27/28 p &lt; 0.01 4/94 vs 27/28 p &lt; 0.01 

Animal handlers vs 
blood donors 

2/94 vs 0/152 p Z 0.15 0/94 vs 0/152 p Z 1.0 
13/94 vs 0/152 p &lt; 0.01 4/94 vs 0/152 p Z 0.02 

SARS patients vs 
blood donors 

17/28 vs 0/152 p &lt; 0.01 7/28 vs 0/152 p &lt; 0.01 27/28 vs 0/152 p &lt; 0.01 27/28 vs 0/152 p &lt; 0.01 

IF, immunofluorescence; NT, neutralization. 
a Antibody titer !20 for immunoflourescence assay and !10 for neutralization assay. 
</table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1" validated="false"><head></head><label></label><figDesc>HCoV-OC43 IF HCoV-229E IF HCoV-NL63 IF</figDesc><table>SARS patients with paired sera (n Z 4) 
Case A (acute) 
&lt;1:20 
&lt;1:10 
&lt;1:20 
&lt;1:10 
1:80 
1:80 
&lt;1:20 
Case A (convalescent) &lt;1:20 
&lt;1:10 
1:160 
1:20 
1:160 
1:40 
&lt;1:20 
Case B (acute) 
1:20 
&lt;1:10 
&lt;1:20 
&lt;1:10 
1:80 
1:20 
1:40 
Case B (convalescent) &lt;1:20 
&lt;1:10 
1:160 
1:160 
1:640 
1:20 
1:20 
Case C (acute) 
&lt;1:20 
&lt;1:10 
&lt;1:20 
&lt;1:10 
1:160 
1:40 
&lt;1:20 
Case C a (convalescent) 
1:40 
&lt;1:10 
1:640 
1:80 
1:640 
1:20 
&lt;1:20 
Case D (acute) 
&lt;1:20 
&lt;1:10 
&lt;1:20 
&lt;1:10 
1:160 
1:20 
&lt;1:20 
Case D b (convalescent) 
1:320 
&lt;1:10 
1:160 
1:80 
1:1280 
1:80 
1:20 

IF, immunofluorescence; NT, neutralization. 
a Case C (convalescent) in </table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2" validated="true"><head>Table 2</head><label>2</label><figDesc>Titers of anti-HCoV-EMC and anti-SARS-CoV antibodies by immunofluorescence and neutralization among animal handlers and SARS patients with positive immunofluorescent anti-HCoV-EMC antibodies.</figDesc><table>HCoV-EMC IF 
HCoV-EMC NT 
SARS-CoV IF 
SARS-CoV NT 
HCoV-OC43 IF 
HCoV-OC43 NT 

Animal handlers (n Z 2) 
Case 1 
1:20 
&lt;1:10 
1:40 
&lt;1:10 
1:640 
Not available c 
Case 2 
1:40 
&lt;1:10 
1:40 
&lt;1:10 
1:320 
1:80 
SARS patients (n Z 17) 
Case 1 
1:20 
1:20 
1:160 
1:80 
1:320 
1:160 
Case 2 
1:40 
&lt;1:10 
1:320 
1:80 
1:640 
1:160 
Case 3 a 
1:40 
&lt;1:10 
1:640 
1:80 
1:640 
1:80 
Case 4 
1:40 
&lt;1:10 
1:1280 
1:80 
1:320 
1:160 
Case 5 
1:80 
1:10 
1:320 
1:80 
1:320 
1:80 
Case 6 
1:80 
1:10 
1:640 
1:160 
1:320 
1:40 
Case 7 
1:80 
1:10 
1:640 
1:160 
1:640 
1:320 
Case 8 
1:80 
&lt;1:10 
1:640 
1:80 
1:640 
1:160 
Case 9 
1:80 
1:10 
1:1280 
1:320 
1:640 
1:320 
Case 10 
1:80 
&lt;1:10 
1:1280 
1:80 
1:320 
1:80 
Case 11 
1:160 
&lt;1:10 
1:320 
1:80 
1:320 
1:80 
Case 12 
1:160 
1:20 
1:640 
1:160 
1:1280 
1:160 
Case 13 
1:160 
1:10 
1:1280 
1:160 
1:640 
1:160 
Case 14 
1:160 
&lt;1:10 
1:1280 
1:160 
1:640 
1:80 
Case 15 
1:160 
&lt;1:10 
1:2560 
1:160 
1:1280 
1:80 
Case 16 
1:160 
&lt;1:10 
1:2560 
1:160 
1:2560 
1:320 
Case 17 b 
1:320 
&lt;1:10 
1:160 
1:80 
1:1280 
1:160 

IF, immunofluorescence; NT, neutralization. 
a Case 3 in </table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interests</head><p>None.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">F</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">K</forename><surname>To</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">C</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="477" to="89" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
				<idno>ac- cessed 26.03.13</idno>
		<ptr target="http://www.who.int/csr/don/2013_03_26/en/index.html" />
		<title level="m">Global alert and response: novel coronavirus infection e update</title>
		<meeting><address><addrLine>Geneva</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Latest outbreak news from ProMED-mail: novel coronavirus e Middle East</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">P</forename><surname>Pollack</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Pringle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">C</forename><surname>Madoff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">A</forename><surname>Memish</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Infect Dis</title>
		<imprint>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1201" to="9712" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Zaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Van Boheemen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">M</forename><surname>Bestebroer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">D</forename><surname>Osterhaus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Fouchier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<biblScope unit="page" from="1814" to="1834" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Genetic relatedness of the novel human lineage C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">K</forename><surname>Tsang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
		<idno type="DOI">10.1038/emi.2012.45</idno>
		<ptr target="http://dx.doi.org/10.1038/emi.2012.45" />
	</analytic>
	<monogr>
		<title level="j">Emerg Microbe Infect</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">35</biblScope>
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Van Boheemen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>De Graaf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Lauber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">M</forename><surname>Bestebroer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">S</forename><surname>Raj</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Am</forename><surname>Zaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">MBio</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="473" to="485" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">W</forename><surname>Poon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Guo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="1574" to="85" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Annan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">J</forename><surname>Baldwin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">M</forename><surname>Corman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sm</forename><surname>Klose</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Owusu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">E</forename><surname>Nkrumah</surname></persName>
		</author>
		<ptr target="http://wwwnc.cdc.gov/eid/article/19/3/12-1503_article.htm" />
	</analytic>
	<monogr>
		<title level="j">Emerg Infect Dis</title>
		<imprint>
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Circulation of group 2 coronaviruses in a bat species common to urban areas in Western Europe</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">B</forename><surname>Reusken</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">H</forename><surname>Lina</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Pielaat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>De Vries</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Dam-Deisz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Adema</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vector Borne Zoonotic Dis</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="785" to="91" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Severe respiratory illness caused by a novel coronavirus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Bermingham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Chand</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Aarons</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Langrish</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Euro Surveill</title>
		<imprint>
			<biblScope unit="volume">2012</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page">2020290</biblScope>
			<date type="published" when="2012-09" />
		</imprint>
	</monogr>
	<note>in a patient transferred to the United Kingdom from the Middle East</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">C</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Rev</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="660" to="94" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">W</forename><surname>Tsoi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">H</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><forename type="middle">Y</forename><surname>Che</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">363</biblScope>
			<biblScope unit="page" from="841" to="846" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Coronavirus HKU1 and other coronavirus infections in Hong Kong</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">C</forename><surname>Yip</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Tse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">W</forename><surname>Tsoi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">C</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="2063" to="71" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">W</forename><surname>Tsoi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">W</forename><surname>Tsoi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">W</forename><surname>Poon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">192</biblScope>
			<biblScope unit="page" from="1898" to="907" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">A previously undescribed coronavirus associated with respiratory disease in humans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Fouchier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">G</forename><surname>Hartwig</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">M</forename><surname>Bestebroer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Niemeyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Simon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U.S.A</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="6212" to="6218" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Identification of a new human coronavirus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Van Der Hoek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Pyrc</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">F</forename><surname>Jebbink</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Vermeulen-Oost</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">J</forename><surname>Berkhout</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">C</forename><surname>Wolthers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="368" to="73" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Cultivation of viruses from a high proportion of patients with colds</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Tyrrell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">L</forename><surname>Bynoe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="76" to="83" />
			<date type="published" when="1966" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">A new virus isolated from the human respiratory tract</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Hamre</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Procknow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Soc Exp Biol Med</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="190" to="193" />
			<date type="published" when="1966" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">W</forename><surname>Tsoi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">H</forename><surname>Wong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="14040" to="14045" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">K</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Peiris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">N</forename><surname>Tsang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">L</forename><surname>Que</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">F</forename><surname>Shortridge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">351</biblScope>
			<biblScope unit="page" from="467" to="71" />
			<date type="published" when="1998" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Avian influenza A (H5N1) infection in humans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Beigel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Farrar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">G</forename><surname>Hayden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Hyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>De Jong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">353</biblScope>
			<biblScope unit="page" from="1374" to="85" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Avian influenza A H5N1 virus: a continuous threat to humans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">K</forename><surname>To</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">L</forename><surname>Que</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Y</forename><surname>Tsang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">K</forename><surname>Tsang</surname></persName>
		</author>
		<idno type="DOI">10.1038/emi.2012.24</idno>
		<ptr target="http://dx.doi.org/10.1038/emi.2012.24" />
	</analytic>
	<monogr>
		<title level="j">Emerg Microbe Infect</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">25</biblScope>
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications on disease pathogenesis and clinical manifestation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">F</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">K</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">K</forename><surname>To</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Tse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Cai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<date type="published" when="2013-04-11" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Human coronavirus emc does not require the SARScoronavirus receptor and maintains broad replicative capability in mammalian cell lines</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>M€ Uller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Raj</forename><surname>Vs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Muth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Kallies</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">L</forename><surname>Smits</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">MBio</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="515" to="527" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">M</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">W</forename><surname>Tsoi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="884" to="95" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Examination of seroprevalence of coronavirus HKu1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">M</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Tse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">S</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Virol</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="54" to="60" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">J</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">W</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">P</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">J</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="8091" to="8097" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">C</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">L</forename><surname>Poon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Guan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Diagn Lab Immunol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1317" to="1338" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">H</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">W</forename><surname>Tsoi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Fung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">Y</forename><surname>Kao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="3054" to="3062" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">H</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">T</forename><surname>Hui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">S</forename><surname>Kwan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="5885" to="5893" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">H</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">W</forename><surname>Tsoi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Fung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Chan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="2306" to="2315" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzymelinked immunosorbent assay</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">H</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">W</forename><surname>Tsoi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">K</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">W</forename><surname>Poon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="2884" to="2893" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">PROMALS3D web server for accurate multiple protein sequence and structure alignments</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Pei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">V</forename><surname>Grishin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="30" to="34" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Epitopia: a webserver for predicting B-cell epitopes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">D</forename><surname>Rubinstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Mayrose</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Martz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Pupko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Bioinform</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">287</biblScope>
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Krogh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Larsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Von Heijne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">L</forename><surname>Sonnhammer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Biol</title>
		<imprint>
			<biblScope unit="volume">305</biblScope>
			<biblScope unit="page" from="567" to="80" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">An HMM model for coiled-coil domains and a comparison with PSSM-based predictions</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Delorenzi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Speed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="617" to="642" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">A</forename><surname>Elshabrawy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">M</forename><surname>Coughlin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">C</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">S</forename><surname>Prabhakar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">50366</biblScope>
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><forename type="middle">Y</forename><surname>Che</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">W</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">X</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Wen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Hao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">Y</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="2629" to="2664" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">G</forename><surname>Blanchard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Miao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">E</forename><surname>Haupt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">J</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Haynes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol Methods</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="page" from="100" to="106" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptorbinding domain of spike protein</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Lustigman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Farzan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="6085" to="92" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Amino acids 15-28 in the ectodomain of SARS coronavirus 3a protein induces neutralizing antibodies</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Akerström</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">J</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Mirazimi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">580</biblScope>
			<biblScope unit="page" from="3799" to="803" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><forename type="middle">J</forename><surname>Buchholz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Bukreyev</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">W</forename><surname>Lamirande</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">R</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Subbarao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="9804" to="9813" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">K</forename><surname>Debnath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect</title>
		<imprint>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="163" to="4453" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virology</title>
		<imprint>
			<biblScope unit="volume">339</biblScope>
			<biblScope unit="page" from="213" to="238" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Viral loads in clinical specimens and SARS manifestations</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">F</forename><surname>Hung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">C</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">K</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">S</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">M</forename><surname>Chu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Emerg Infect Dis</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1550" to="1557" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Corman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>M€ Uller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Costabel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Timm</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Binger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Meyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Euro Surveill</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">20334</biblScope>
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">J</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">L</forename><surname>Hez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Zheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antivir Ther</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="393" to="403" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Use of convalescent plasma therapy in SARS patients in Hong Kong</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">O</forename><surname>Soo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">S</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">H</forename><surname>Ng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Microbiol Infect Dis</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="44" to="50" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Comparative analysis of complete genome sequences of three avian coronaviruses reveals a novel group 3c coronavirus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename><surname>Lam</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">K</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="908" to="925" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltavoronavirus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename><surname>Lam</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">C</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">K</forename><surname>Tsang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Lau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="3995" to="4008" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Isolation and characterization of a novel betacoronavirus subgroup A coronavirus, rabbit coronavirus HKU14, from domestic rabbits</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">C</forename><surname>Yip</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">Y</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="5481" to="96" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Coexistence of different genotypes in the same bat and serological characterization of Rousettus bat coronavirus HKU9 belonging to a novel Betacoronavirus subgroup</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">W</forename><surname>Poon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">H</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Huan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="11385" to="94" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Complete genome sequence of bat coronavirus HKU2 from Chinese horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage from the rest of the genome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename><surname>Lam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virology</title>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<biblScope unit="page" from="428" to="467" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Coronavirus diversity, phylogeny and interspecies jumping</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Biol Med (Maywood)</title>
		<imprint>
			<biblScope unit="volume">234</biblScope>
			<biblScope unit="page" from="1117" to="1144" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Infectious diseases emerging from Chinese wet-markets: zoonotic origins of severe respiratory viral infections</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="401" to="408" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Recent transmission of a novel alphacoronavirus, bat coronavirus HKU10, from Leschenault&apos;s rousettes to pomona leafnosed bats: first evidence of interspecies transmission of coronavirus between bats of different suborders</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">K</forename><surname>Tsang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">T</forename><surname>Shek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">K</forename><surname>Choi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="11906" to="11924" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">K</forename><surname>Tsang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">C</forename><surname>Yip</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Tse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="11325" to="11362" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">The severe acute respiratory syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Peiris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">D</forename><surname>Osterhaus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Stöhr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">349</biblScope>
			<biblScope unit="page" from="2431" to="2472" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Coronavirus as a possible cause of severe acute respiratory syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Peiris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">T</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">L</forename><surname>Poon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">Y</forename><surname>Yam</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Lim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">361</biblScope>
			<biblScope unit="page" from="1319" to="1344" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Aetiology: Koch&apos;s postulates fulfilled for SARS virus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Fouchier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kuiken</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Schutten</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Van Amerongen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">J</forename><surname>Van Doornum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">G</forename><surname>Van Den Hoogen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">423</biblScope>
			<biblScope unit="page">240</biblScope>
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">A novel coronavirus associated with severe acute respiratory syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">G</forename><surname>Ksiazek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Erdman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename><surname>Goldsmith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">R</forename><surname>Zaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Peret</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Emery</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Identification of a novel coronavirus in patients with severe acute respiratory syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Drosten</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>G€ Unther</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Preiser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Van Der Werf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">R</forename><surname>Brodt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Becker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">347</biblScope>
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">T</forename><surname>Keng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">M</forename><surname>Lip</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">C</forename><surname>Fielding</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">H</forename><surname>Tan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="3289" to="9326" />
			<date type="published" when="2005-03" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
